Cyclin D1 expression was not significantly associated to breast cancer mortality in the study population when ER-positive and ER-negative cases were analyzed together (OR 0.94, 95% CI 0.63–1.4, p = 0.76). Here, CCND1 is linked to breast carcinoma.